本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mineralys Therapeutics, Inc.

29.71
+0.78002.70%
成交量:56.45万
成交额:1,654.97万
市值:23.51亿
市盈率:-10.38
高:29.98
开:28.61
低:27.76
收:28.93
52周最高:47.65
52周最低:8.24
股本:7,914.00万
流通股本:5,573.32万
量比:0.60
换手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-2.8636
每股收益(LYR):-3.6632
净资产收益率:-42.14%
总资产收益率:-26.50%
市净率:4.08
市盈率(LYR):-8.11

数据加载中...

2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]